Related Experiment Video

Updated: May 5, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet

Xin Yang1, Xiao-Fei Zhang, Xu Lu

  • 1Liver Cancer Institute & Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China. Key Laboratory of Carcinogenesis & Cancer Invasion, Ministry of Education, China.

Hepatology (Baltimore, Md.)
|November 22, 2013
PubMed
Abstract

Insights

MicroRNA-26a (miR-26a) suppresses hepatocellular carcinoma (HCC) angiogenesis by inhibiting HGF-cMet signaling, reducing VEGFA. High miR-26a indicates a better prognosis for HCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • Tumor angiogenesis is crucial for HCC growth and metastasis.
  • MicroRNA-26a (miR-26a) has shown potential in suppressing HCC progression.

Purpose of the Study:

  • To investigate the role of miR-26a in HCC tumor angiogenesis.
  • To elucidate the molecular mechanisms underlying miR-26a's anti-angiogenic effects.
  • To evaluate miR-26a as a prognostic marker in HCC.

Main Methods:

  • Gain- and loss-of-function studies in HCC cells.
  • Analysis of vascular endothelial growth factor A (VEGFA) and hepatocyte growth factor (HGF) expression.
  • In vitro endothelial cell assays (proliferation, migration, tube formation).
  • In vivo tumor angiogenesis assessment.
  • Correlation analysis with patient prognosis (overall survival, time to recurrence).

Main Results:

  • Down-regulation of miR-26a correlated with increased angiogenic potential in HCC.
  • miR-26a significantly inhibited VEGFA expression and HCC-driven angiogenesis.
  • HGF was identified as a direct target of miR-26a.
  • miR-26a suppressed angiogenesis via the HGF-cMet pathway, reducing VEGFA and VEGFR2 signaling.
  • High miR-26a, low HGF, low VEGFA, and low microvessel density predicted better patient outcomes.

Conclusions:

  • miR-26a suppresses HCC tumor angiogenesis through the HGF-cMet signaling pathway.
  • miR-26a represents a potential therapeutic target for HCC.
  • miR-26a serves as a novel prognostic marker for HCC patients.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K